ArticleFrontiers in cardiovascular medicine2025
Successful treatment of iodixanol-induced type II Kounis syndrome with an intra-aortic balloon pump: a case report and literature review.
Article in Frontiers in cardiovascular medicine, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
- Contrast Media Side Effects and Kounis Syndrome: Timeo Danaos et Dona Ferentes.Balkan medical journal · 2026Review
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Background: Kounis syndrome (KS) is an acute coronary syndrome triggered by hypersensitivity reactions and is often underrecognized in clinical practice. This report describes a case of iodixanol-induced KS that was refractory to standard emergency medications but successfully managed with an intra-aortic balloon pump (IABP), along with a review of similar published cases. Case summary: A 77-year-old woman with a history of chest pain underwent coronary angiography with iodixanol. During the procedure, she developed progressive bradycardia, hypotension, and convulsions. Despite immediate cardiopulmonary resuscitation and the administration of emergency medications, hypotension persisted. Hemodynamic stability was rapidly achieved following IABP implantation, with complete resolution of symptoms and no complications. This case represents the first reported instance of iodixanol-induced KS that was unresponsive to conventional vasoactive drugs and required IABP for stabilization. A review of the literature identified four prior cases of iodixanol-induced KS, all of which were successfully managed with medical therapy alone, highlighting the unique severity and therapeutic challenge of the present case. Conclusion: This is the first reported use of IABP for iodixanol-induced KS, suggesting its potential role in refractory cases.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.